|Bid||1,265.00 x 0|
|Ask||1,270.00 x 0|
|Day's Range||1,250.00 - 1,330.00|
|52 Week Range||1,250.00 - 1,795.00|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 30, 2018 - Aug 3, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1,618.30|
PT Kalbe Farma, whose antacid drug Promag is a household name in Indonesia, is seeking a partner in Sri Lanka and eyeing the Middle East as a new market for its nutritional products.
By Sumeet Gaikwad Oct 4 (Reuters) - Philippine and Indonesian shares posted record closing highs on Wednesday as overnight gains on Wall Street buoyed sentiment across Asia, while Thailand edged down after ...